<DOC>
	<DOCNO>NCT00258622</DOCNO>
	<brief_summary>Purpose : To evaluate efficacy , tolerability safety NS1209 compare lidocaine placebo patient peripheral chronic neuropathic pain .</brief_summary>
	<brief_title>NS1209 Lidocaine Patients With Peripheral Neuropathic Pain</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<criteria>Age &gt; 18 year Neuropathic pain allodynia peripheral nerve injury ( VAS &gt; = 4 ) Patients cooperate understand Danish Fertile woman Clinically significant abnormality disease Drug alcohol abuse Clinically abnormal ECG Hypersensitivity treatments Patients treatment cimetedin , antidepressant , antipsychotic , antiepileptic except gabapentin , anticoagulant , Na channel blocker beta blocker Patients previously treat NS1209 study Patients treat investigational drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>Peripheral neuropathic pain</keyword>
	<keyword>Neuropathic pain</keyword>
	<keyword>Chronic pain</keyword>
</DOC>